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Salmonella species utilize type III secretion systems (T3SSs) to translocate effectors into the cytosol of mammalian host cells,
subverting cell signaling and facilitating the onset of gastroenteritis. In this study, we compared a draft genome assembly of Sal-
monella enterica subsp. salamae strain 3588/07 against the genomes of S. enterica subsp. enterica serovar Typhimurium strain
LT2 and Salmonella bongori strain 12419. S. enterica subsp. salamae encodes the Salmonella pathogenicity island 1 (SPI-1),
SPI-2, and the locus of enterocyte effacement (LEE) T3SSs. Though several key S. Typhimurium effector genes are missing (e.g.,
avrA, sopB, and sseL), S. enterica subsp. salamae invades HeLa cells and contains homologues of S. bongori sboK and sboC,
which we named seoC. SboC and SeoC are homologues of EspJ from enteropathogenic and enterohemorrhagic Escherichia coli
(EPEC and EHEC, respectively), which inhibit Src kinase-dependent phagocytosis by ADP-ribosylation. By screening 73 clinical
and environmental Salmonella isolates, we identified EspJ homologues in S. bongori, S. enterica subsp. salamae, and Salmonella
enterica subsp. arizonae. The-lactamase TEM-1 reporter system showed that SeoC is translocated by the SPI-1 T3SS. All the
Salmonella SeoC/SboC homologues ADP-ribosylate Src E310 in vitro. Ectopic expression of SeoC/SboC inhibited phagocytosis
of IgG-opsonized beads into Cos-7 cells stably expressing green fluorescent protein (GFP)-FcRIIa. Concurrently, S. enterica
subsp. salamae infection of J774.A1macrophages inhibited phagocytosis of beads, in a seoC-dependent manner. These results
show that S. bongori, S. enterica subsp. salamae, and S. enterica subsp. arizonae share features of the infection strategy of extra-
cellular pathogens EPEC and EHEC and shed light on the complexities of the T3SS effector repertoires of Enterobacteriaceae.
Salmonella strains comprise a large group of foodborne bacte-rial pathogens of the gastrointestinal tract. Originally, the ge-
nus Salmonella was divided into seven subspecies (I, II, IIIa, IIIb,
IV, V, and VI [1]) but is currently classified as two species, Salmo-
nella bongori, previously subspecies V, and Salmonella enterica.
The remaining subspecies have been renamed under the S. en-
terica species as enterica (I), salamae (II), arizonae (IIIa), diarizo-
nae (IIIb), houtenae (IV), and indica (VI), which are further di-
vided into over 2,600 serovars based on their O (oligosaccharide)
and H (flagellar) antigens (2).
It is estimated that salmonellosis, the disease caused by con-
sumption of contaminated food and water, is responsible for ap-
proximately 1.2 million cases and 450 fatalities per annum in the
United States alone (3). Reservoirs of Salmonella spp. can be
found in a range of domestic and wild animals, such as cattle,
swine, poultry, and birds (4). In addition, exposure to exotic rep-
tiles has been increasingly reported as a source of infection due to
their growing popularity as pets (5). Salmonellae can cause a va-
riety of conditions aside from the local diarrheal disease, including
bacteremia, osteomyelitis, and enterocolitis (6).
The majority of salmonellosis cases observed in mammals and
birds are a result of infections with S. enterica subsp. enterica. As a
result, research into the remaining five S. enterica subspecies and
S. bongori, often considered nonpathogenic commensals of cold-
blooded vertebrates, is limited to date. Nevertheless, these other
salmonellae do cause sporadic disease in mammals, with children
and immunocompromised individuals most at risk (7–9). Several
fatalities have been reported, and clinical evidence suggests that as
a proportion of cases, those infections caused by non-enterica (I)
subspecies are more likely to cause invasive extraintestinal disease
(10).
Salmonellae encode two virulence-associated type III secretion
systems (T3SSs) on Salmonella pathogenicity island 1 (SPI-1) and
SPI-2, which are required for different stages of salmonellosis.
T3SSs are macromolecular syringes, which translocate effectors
into the membrane and cytosol of cells lining the gastrointestinal
mucosae. The SPI-1 T3SS and its effectors are required for the
initial infection process involving the invasion of nonphagocytic
cell epithelium and M-cells and the stimulation of diarrhea (re-
viewed in reference 11). Once internalized, the bacterium resides
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within the specialized Salmonella-containing vacuole (SCV),
where the SPI-2 is utilized for bacterial replication and systemic
spreading of the infection. Recent reports have shown that Salmo-
nella enterica subsp. salamae strains 1582 (serotype 58:d:z6), 1583
(serotype 47:b:1,5) (12), S1635, and S1296 (serovar Sofia, serotype
1,4,12,27:b:) (13) carry genes similar to those carried by the
locus of enterocyte effacement (LEE) pathogenicity island of the
human pathogens enteropathogenic and enterohemorrhagic
Escherichia coli (EPEC and EHEC, respectively) and the mouse
pathogen Citrobacter rodentium, including the T3SS. Unlike
members of S. enterica, S. bongori lacks SPI-2 and its SPI-1 locus
appears to have acquired 11 genes not found in S. enterica subsp.
enterica, 10 of which are homologues of T3SS effectors fromEPEC
and EHEC (14). For example, SboH from S. bongori shares se-
quential and functional homology to the antiapoptotic effector
NleH1 (15). Furthermore, SboC shares 57% sequence identity to
the EPEC antiphagocytic effector EspJ (14).
EPEC EspJ is able to ADP-ribosylate the kinase domain of Src,
preventing the phosphorylation of the Fc-receptor-IIa (FcRIIa)
required for opsonophagocytosis (16, 17), and was the first exam-
ple of a bacterial ADP-ribosyltransferase (ART) to target a mam-
malian tyrosine kinase. Mass spectrometry suggested a novel
mechanism with coupled amidation and ADP-ribosylation of Src
E310, a residue highly conserved throughout the kinase superfam-
ily (18).
While producing a draft genome sequence for S. enterica subsp.
salamae strain 3588/07, we found an espJ/sboC homologue, which
we named SeoC, within a complex effector protein repertoire. The
aim of this study was to determine the prevalence of espJ/sboC/
seoC in representative clinical and environmental isolates from
each of the S. enterica subspecies and to characterize their activity
in relation to EspJ from EPEC, EHEC, and C. rodentium.
MATERIALS AND METHODS
Determination of the effector repertoire of S. enterica subsp. salamae
strain 3588/07. The whole genome of S. enterica subsp. salamae strain
3588/07 was sequenced using paired-end 454 FLX pyrosequencing using
the Titanium chemistry from both 3-kb and 20-kb insert libraries. The
read data were assembled using the 454/Roche Newbler assembly pro-
gram into 138 contigs (N50 contig size, 173,757 bp; N50 scaffold size,
5,041,913 bp) representing 5,116,235 bp of sequence from 631,936 se-
quence reads representing 25 total coverage. We compared a draft as-
sembly of S. enterica subsp. salamae (PATRIC accession no. GCA_
000308035.1) against the genomes of S. enterica subsp. enterica serovar
Typhimurium LT2 and S. bongori 12419. We performed all-against-all
BLAST searches comparing each of these genomes against the S. enterica
subsp. salamae assembly to identify regions with shared sequence similar-
ity.We then visualized the BLAST searches using theArtemisComparison
Tool (19) and used known effectors in the Salmonella enterica serovar
Typhimurium and S. bongori genomes to identify putative coding se-
quences for effectors in the S. enterica subsp. salamae assembly. We veri-
fied their presence based on a combination of direct examination of the
nucleotide or amino acid sequence similarity and identification of their
presence along with the same up- and/or downstream genes present in S.
Typhimurium or S. bongori.
Bacterial strains and growth conditions.Bacterial strains used in this
study can be found in Tables S1 and S2 in the supplemental material.
Bacteria were routinely cultured in Luria-Bertani (LB) broth at 37°C, with
tetracycline (6 g/ml), ampicillin (100 g/ml), or kanamycin (50 g/ml)
as appropriate.
Seventy-three strains were selected from the Collection of the Spanish
National Laboratory for Salmonella. All the S. enterica strains were iso-
lated in Spain, while S. bongori strains were from the National Salmonella
Reference Laboratory at the Centers for Disease Control and Prevention,
Atlanta, GA (see Table S2 in the supplemental material).
Construction of S. enterica subsp. salamae mutants. S. enterica
subsp. salamaemutants (see Table S1 in the supplemental material) were
created using the lambda red recombinase method (20). For S. enterica
subsp. salamae seoC, a PCR product was generated from S. enterica
subsp. salamae including seoC and 500-bp flanking regions using primer
pair 15 (see Table S3) and inserted into pGEMT vector by blunt-ended
ligation. Inverse PCRwith primer pair 16 was used to remove seoC coding
sequence from this plasmid, and the kanamycin resistance cassette ampli-
fied from pKD4 using primer pair 18 was blunt-end ligated into the
pGEMT backbone containing the seoC flanking regions. Primer pair 15
was used to amplify the kanamycin resistance cassette flanked by 500-bp
flanking regions of seoC. For S. enterica subsp. salamae escN/invA/
ssav mutants, the kanamycin resistance cassette from pKD4 was ampli-
fiedwith 50-bp flanking regions of escN, invA, or ssaV on either side, using
primer pairs 20/21/22. PCR products from the two above methods were
transformed by electroporation into electrocompetent S. enterica subsp.
salamae 3558/07 expressing the lambda red genes from an arabinose-
inducible promoter within the pKD46 plasmid (20). Clones were selected
on 50-g/ml kanamycin LB agar, cured by growth at 42°C, and verified by
PCR and DNA sequencing using primer pairs 17/23/24/25 (for seoC/
escN/invA/ssav, respectively), 560 bp flanking the seoC gene, and
primers for the kanamycin cassette.
Plasmid construction. Oligonucleotides for gene amplification and
site-directed mutagenesis are shown in Table S3 in the supplemental ma-
terial, plasmids are shown in Table S4, and the strains from which genes
were amplified are shown in Table S1. Briefly, oligonucleotides were used
to amplify the gene insert fromgenomicDNA, and products were purified
using the Qiagen PCR purification kit according to the manufacturer’s
instructions. Target vectors and PCR products were digested for 1 h at
37°C with restriction enzymes before dephosphorylating the cut vector
with calf intestinal phosphatase (NewEnglandBioLabs [NEB]) for 30min
at 37°C. Inserts and vectors were incubated together at a 3:1 molar ratio
for 20 min at room temperature (RT) with T4 DNA ligase (NEB) before
transformation into Top10 competent cells. Inserts were confirmed by
colony PCR followed by DNA sequencing. Subcloning with EcoRI and
HindIII restriction enzymes was used to “cut and paste” EPEC EspJ from
pRK5-myc-EspJEPEC to pMALXE-EspJEPEC. Site-directed mutagenesis
was performed either by nonoverlapping inverse PCR followed by blunt-
ended ligation or by overlapping inverse PCR and transformation using
the QuikChange II site-directed mutagenesis kit (Agilent) according to
the manufacturer’s instructions.
Screening and sequencing seoC/sboC/espJ orthologues among Sal-
monella isolates. PCR was performed using espJ primers (primer pair 1
[see Table S3 in the supplemental material]) on bacterial boilates using a
PuReTaq-Ready-To-Go PCR bead system (GE Healthcare). The amplifi-
cation products of espJwere purified and sequenced using the same prim-
ers. Sequencing was performed on an ABI Prism 3730XL DNA analyzer
(Applied Biosystems, Applera Hispania, S.A., Spain) using the Taq Dye
Deoxy Terminator cycle sequencing kit (Applied Biosystems/Perkin-El-
mer). Sequences analysis was performed with Lasergene v.5.0 software
(DNAStar, Madison, WI, USA).
Eukaryotic cell maintenance.Cos-7, J774.A1, andHEK293 cells were
maintained in Dulbecco’s modified Eagle’s medium (DMEM; Sigma-Al-
drich) containing 4,500 mg/liter glucose supplemented with 10% (vol/
vol) heat-inactivated fetal calf serum and 1% (vol/vol) GlutaMAX (Life
Technologies) at 37°C and 5%CO2.HeLa cells were similarlymaintained,
only with 1,000 mg/liter glucose. Green fluorescent protein (GFP)-
FcIIa-stably transduced Cos-7 cells had the addition of 0.1 g/ml of
puromycin.
Translocation assay. The -lactamase (TEM-1) translocation assay
was performed as previously described (14). Briefly, 8 103HeLa/4 103
J774.A1 cells were seeded per well of a 96-well plate (BD Falcon; catalogue
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no. 353948) 48 h prior to infection. Overnight cultures of S. enterica
subsp. salamae strains were diluted 1:33 and grown for 2 h at 37°C with
shaking before inducing TEM fusion expression from pCX340 (21) with
0.05 mM isopropyl--D-1-thiogalactopyranoside (IPTG). Cultures were
then incubated to an optical density at 600 nm (OD600) of 1.8 (typically a
further 30 min) and used to infect monolayers with a multiplicity of in-
fection (MOI) of 100 for 1 h at 37°C, 5% CO2. The cell monolayers were
washed with 100 l Hanks’ buffered salt solution (Gibco), supplemented
with 20 mM HEPES and 3 mM probenecid (Sigma), pH 7.4, and devel-
oped as described previously (14). Fluorescence emission at 450 nm and
520 nm was measured using a FLUOstar Optima plate reader (excitation
wavelength, 410 nm; 10-nm band-pass). The translocation rate was cal-
culated as recommended in the Live Blazer FRET-B/G loading kitmanual.
Expression of the TEM-1 fusion proteins was analyzed by Western blot-
ting using amouse anti--lactamase antibody (QED Bioscience Inc.; data
not shown).
Protein overexpression. EspJ homologues were cloned into pMALX(E)
(22) backbone and Src 250–533K295M/Y416F (Src250–533KY) and Src 250–
533K295M/Y416F/E310A (Src250–533KYE) were cloned into pGEX-KG to pro-
duce an N-terminally maltose binding protein (MBP)-tagged fusion and
N-terminally glutathione S-transferase (GST)-tagged fusions, respec-
tively. These vectors were transformed into BL21-STAR competent cells
(Novagen), and overnight cultures were used to inoculate 1:100 of fresh
LB broth. After growth to an OD600 of 0.6 at 37°C, protein expression
from the T7 promoter was induced with 1 mM IPTG at 18°C overnight.
Cells harvested at 4,500 relative centrifugal force (RCF) were resuspended
in MBP lysis buffer (500 mM NaCl, 50 mM N-cyclohexyl-3-aminopro-
panesulfonic acid [CAPS], 5 mM dithiothreitol [DTT], 10% glycerol, pH
11) or GST lysis buffer (300mMNaCl, 50mMNa2HPO4, 5mMDTT, 5%
glycerol, pH 7.4) before cell disruption by sonication and clarification at
40,000 RCF.
GST-Src 250–533 purifications. Lysis supernatant was passed over a
GSTrap 4B Sepharose column (GE Healthcare) to bind GST fusion pro-
teins, and nonspecific interaction mixtures were washed with a 20 col-
umn volume of GST lysis buffer before being eluted with 20 mM reduced
glutathione-containing elution buffer. Next, gel filtration in lysis buffer
using a Superdex 200 10/300 gel filtration column (Invitrogen) was uti-
lized to remove protein aggregates.
In vitro ADP-ribosylation assay. Five hundred microliters of lysis
supernatant was incubated with 50 l of amylose resin (Novagen) for 1 h
at 4°C with rotation. After washing 3 times with MBP lysis buffer, 4 g of
GST-tagged Src250–533KY or Src250–533KYE and 10M6-biotin-17-NAD

(AMSBio) in phosphate-buffered saline (PBS), pH 7.4, were added. After
1 h, room-temperature (RT) Laemmli buffer was added and samples were
boiled to stop the reaction.
Western immunoblotting. After separation by SDS-PAGE, the Bio-
Rad Transblot semidry transfer cell was used to transfer samples to a
polyvinylidene difluoride (PVDF)membrane for 1 h at 15 V.Membranes
were blocked for 1 h at RT with 5% skim milk–PBS-Tween (PBST) (Sig-
ma-Aldrich) before sequential incubation with primary and secondary
antibodies in 1% skim milk-PBST for 1 h each with washing in between
(see Table S5 in the supplemental material).
Construction of a stably transduced Cos-7 GFP-FcRIIa cell line.
GFP-FcRIIa was cloned frompEGFP-FcRIIa (23) into pMXs-IP (Invit-
rogen). HEK293 cells were seeded in a 6-well plate (Becton Dickinson) at
4.8  104 cells per well 24 h before transfection. Cells were transfected
with 500 ng pMX-IP–GFP-FcRIIa, 400 ng of Moloney murine leukemia
virus (MMLV) plasmid, and 100 ng of vesicular stomatitis virus G protein
(VSV-G) plasmid using Lipofectamine (Invitrogen) according to the
manufacturer’s protocol. After 24 h, transfected cells were washed and
fresh medium was added, allowing the cells to produce virions for a fur-
ther 24 h when the GFP-FcRIIa packaged virion-containing supernatant
was collected. HEPES buffer was added to a final concentration of 20mM,
and the supernatant was filtered through a non-PVDF membrane before
being added to a 70 to 90% confluent T25 flask of Cos-7 cells. After 24 h,
the transduction of GFP-FcRIIa was confirmed by fluorescence micros-
copy. Transduced cells were selectedwith 0.3g/ml puromycin for 1week
before fluorescence-activated cell sorting (FACS) using a BD FACS Aria
III cell sorter and assessed using a BD FACS Fortessa III cell analyzer.
Transfection of Cos-7 GFP-FcRIIa cells.Glass coverslips in 24-well
tissue culture plates (BectonDickinson)were seededwith 5 104 cells per
well 24 h prior to transfection. Cells were transfected using Genejuice
transfection reagent (Novagen) at a 3:1Genejuice/DNA ratio according to
the manufacturer’s instructions. DNA at 0.5 g/well was transfected for
14 to 16 h before subjection to the opsonophagocytosis protocol.
S. enterica subsp. salamae infection of J774.A1/HeLa cells. J774.A1/
HeLa cells were seeded on glass coverslips in a 24-well plate at 1.5 
105/7.5 104 cells per well 24 h before infection, respectively. Overnight
S. enterica subsp. salamae cultures were diluted 1:33 in Lennox-LB broth
and incubated for 2.5 h at 37°C with shaking for 2.5 h to an OD600 of 0.8
before infection of macrophages with an MOI of 100. For complementa-
tion, genes were expressed from the pWSK29 backbone (24) using 0.05
mM IPTG 30 min prior to and during the infection. After 30 min of
infection, bacterium-containing medium was removed and infected cells
were challenged with opsonized beads as described below. For assessment
of the bacterial invasion/internalization, S. enterica subsp. salamae ex-
pressing GFP from the pFPV25.1 plasmid (25) was used for infection.
External bacteria were stained prepermeabilization using the BacTrace
goat anti-CSA-1 antibody (Kirkegaard & Perry Laboratories [KPL]).
Gentamicin protection invasion assay. HeLa cells were infected as
described above, washed with PBS after 60 min, and incubated with
gentamicin-containing medium (200 g/ml) for a further 60 min.
Cells were then washed 5 times with PBS and lysed with 0.1% Triton
X-100 before being plated in serial dilutions on LB agar to assess the
number of CFU. Internalization is expressed as a percentage of the
calculated inoculum.
LDH release cytotoxicity assay. J774.A1 cells were infected as de-
scribed above, taking supernatant samples at 30 and 60 min. After
centrifugation at 4,000 RCF followed by 20,000 RCF to remove mam-
malian and bacterial cells, supernatants were assessed for lactate dehy-
drogenase (LDH) release using the CytoTox 96 nonradioactive cyto-
toxicity assay (Promega) according to the manufacturer’s protocol.
Absorbance at 490 nm was measured using a medium-only control to
calculate the net absorbance, and readings were normalized to unin-
fected controls.
Bead opsonization and opsonophagocytosis assay. Transfected cells
were incubated for 2 h with serum-free DMEM (SF-DMEM).Meanwhile,
3.4-m Sphero bovine serum albumin (BSA)-coated polystyrene beads
(Spherotech)were opsonized for phagocytosis. Per coverslip, 10l (Cos-7
GFP-FcRIIa cells) or 2.5 l (J774.A1 cells) of bead slurry was washed in
1 ml of 20 mM 2-(N-morpholino)ethanesulfonic acid (MES)-8 mM
HEPES before incubation with rotation with mouse anti-BSA primary
antibody at room temperature (RT). After 1 h, opsonized beads were
harvested and resuspended in 1ml SF-DMEM (Cos-7 GFP-FcRIIa cells)
or serum-containing DMEM (J774.A1 cells) per coverslip before addition
to transfected/infected cells. Beads were centrifuged onto the cells at 500
RCF for 5 min. Transfected cells were incubated at 4°C for 15 min before
bead-containing medium was replaced with serum-containing DMEM,
and phagocytosis was allowed to occur for 90 min. Infected macrophages
were incubated with beads for 30 min at 37°C with 5% CO2. Infected/
transfected cells were then washed once with cold tissue-grade PBS on ice
before a 7-min staining of extracellular beads using donkey anti-mouse
Alexa 488/RRX antibody on 0.2% BSA-PBS before washing twice with
PBS and fixation with 3.7% paraformaldehyde (PFA)-PBS for 25 min.
Immunofluorescence staining. Fixed cells were neutralized with 50
mMNH4Cl-PBS for 15 min and permeabilized with 0.2% Triton X-100–
PBS for 2min. Nonspecific bindingwas blocked using 0.2%bovine serum
albumin (BSA)-PBS for 15min prior to incubationwith primary antibod-
ies (see Table S5 in the supplemental material). After 45 min, cells were
Pollard et al.
3620 iai.asm.org December 2016 Volume 84 Number 12Infection and Immunity
 o
n
 January 18, 2017 by LO
NDO
N SCHO
O
L O
F HYG
IENE & TRO
PICAL M
EDICINE
http://iai.asm
.org/
D
ow
nloaded from
 
washed 3 times with PBS before being blocked again and incubated with
secondary antibodies.
Quantification of bead internalization. The internalization of beads
associated with either transfected GFP-FcRIIa Cos-7 cells or S. enterica
subsp. salamae-infected J774.A1 cells was countedmanually by immuno-
fluorescence microscopy. Transfected cells were detected using chicken
anti-myc antibody (Bethyl Laboratories), and bacteria were visualized
with BacTrace goat anti-CSA-1 antibody (KPL).
TABLE 1 Comparison of Salmonella T3SS effectorsa
Secretion system
or gene
Genomic
location
Secreting
system(s)
Presence or absence of T3SS effector system or protein in Salmonella strainb:
S. enterica
subsp.
salamae
3588/07
S. enterica
subsp.
salamae
1582
S. enterica
subsp.
salamae
1583
S. enterica
subsp.
arizonae
CDC346-86
S. bongori
12419
S. Typhimurium
LT2
Secretion systems
SPI-1 T3SS      
SPI-2 T3SS      
Gene name
avrA SPI-1 SPI-1      
sboC/seoC ROD SPI-1      
sipA (sspA) SPI-1 SPI-1      
sipB (sspB) SPI-1 SPI-1      
sipC (sspC) SPI-1 SPI-1      
sopA BB SPI-1  4 5   
sopD BB SPI-1      
sopE fSopE, fSE12 SPI-1  ? ?   
sopE2 BB SPI-1      
sptP SPI-1 SPI-1    	 	 
sopB (sigD) SPI-5 SPI-1 F ? ?   
slrP BB SPI-1 and -2      
sspHI ROD SPI-1 and -2  ? ?   @
gogB fGifsy-1 SPI-2      
pipB SPI-5 SPI-2      
spvB pSLT plasmid SPI-2      
sseI (srfH) fGifsy-2 SPI-2      
sseK1 ROD SPI-2  ? ?   
sseL BB SPI-2  ? ?   
sspH2 SPI-12 SPI-2      
pipB2 ROD SPI-2      
sifA BB SPI-2      
sifB BB SPI-2      
sopD2 BB SPI-2   ?   
spiC (ssaB) SPI-2 SPI-2      
sseF SPI-2 SPI-2      
sseG SPI-2 SPI-2      
sseJ BB SPI-2      
sseK2 ROD SPI-2  ? ?   
steA BB SPI-2  ? ?   
steB BB SPI-2  ? ?   
steC BB SPI-2  ? ?   
sseK3 fSE20   ? ?   &
sboA fSB100 S. bongori T3SS  ? ?   
sboB ROD S. bongori T3SS  ? ?   
sboD ROD S. bongori T3SS  ? ?   
sboE Degenerate f S. bongori T3SS  ? ?  	 
sboF fSB100 S. bongori T3SS  ? ?   
sboG fSB101 S. bongori T3SS  ? ?   
sboH BB S. bongori T3SS  2    
sboI ROD S. bongori T3SS      
sboJ ROD S. bongori T3SS      
sboK ROD S. bongori T3SS      
sboL ROD S. bongori T3SS   2   
a Symbols and abbreviations: ?, presence not confirmed in the work of Desai et al. (12);, present;, absent;	, pseudogene; BB, chromosomal backbone; ROD, region of
difference/genomic island; @, of limited distribution in S. Typhimurium (30); &, carried on phage ST64B of other S. Typhimurium strains (23); F, sopB was missing in S. enterica
subsp. salamae, but there is a fragment of approximately 180 bp that has 58 to 74% sequence similarity to sopB in the same genomic position found in S. bongori.
b Numbers 2, 4, and 5 indicate the number of loci at which the gene is predicted in the genome.
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Accession number(s).The S. enterica subsp. salamae 3588/07 genome
sequencing reads from the 454 platform have been deposited in the Short
Read Archive with accession no. ERR043066.
RESULTS
Effector repertoire of S. enterica subsp. salamae 3588/07. The
majority of sequenced S. enterica strains are from the enterica sub-
species, but recently, a few genomes have been annotated from the
non-enterica subspecies (12, 13, 26).We sequenced the genome of
S. enterica subsp. salamae 3588/07 in order to compare its T3SS
effector repertoire to other Salmonella strains. Of the seven S.
enterica subsp. salamae isolates, four were from a water bath area
which strain 3588/07 was selected to represent. The draft genome
sequence is represented by 140 contigs and is 5,116,236 bp in size.
In agreementwith previously sequenced S. enterica subsp. salamae
strains (12, 13), S. enterica subsp. salamae 3588/07 carries the
SPI-1, SPI-2, and LEE T3SSs, including the signature LEE region
proteins encoded by escN, the ATPase required for EPEC/EHEC
T3SS effector translocation (27), and the translocon proteins
EspA/B/D. The EPEC/EHEC outer membrane adhesin intimin
was present along with six translocated effectors, including the
intimin receptor Tir (28). However, the LEE-encoded effectors
Map, EspG, and EspH were missing (29). The entire effector rep-
ertoire of S. enterica subsp. salamae 3588/07 (Table 1) reveals that
several key effectors found in S. Typhimurium are not present,
including the anti-inflammatory effectors AvrA (29) and GogB
(30) and the deubiquitinase SseL (31) (Table 1). In particular, only
a short, 189-bp fragment of the sopB gene, which is considered a
core effector with regard to Salmonella virulence, is found in the S.
enterica subsp. salamae 3588/07 genome, compared to the 1,686
bp in S. Typhimurium. S. enterica subsp. salamae 3588/07 also
encodes the effectors SteA, SteB, SteC, SopE, SspH1, and SseK2,
which have not beenpreviously found in S. enterica subsp. salamae
strains (12). In addition, the S. bongori effectors SboK and SboC
are also present in S. enterica subsp. salamae 3588/07. SboC is
homologous to the EPEC, EHEC, and C. rodentium antiphago-
cytic effector EspJ; we named the S. enterica subsp. salamae homo-
logue SeoC (Salmonella enterica outer protein C).
Prevalence of sboC/seoC in S. bongori and S. enterica spp.We
investigated the prevalence of seoC across the Salmonella genus by
screening 73 clinical and environmental Salmonella isolates by
PCR. Strain selection was based upon belonging to different spe-
cies/subspecies of Salmonella and to the most frequent serotypes
within each species/subspecies and, if possible, being isolated
from human/nonhuman sources (see Table S2 in the supplemen-
tal material). All tested S. bongori isolates were sboC positive. Of
the S. enterica isolates, seoC was found in 4 out of 7 isolates be-
longing to subspecies salamae and in 8 out of 9 isolates belonging
to subspecies arizonae but not in any isolates of subspecies en-
terica, diarizonae, or houtenae (see Table S2).
Amino acid sequence alignment (Fig. 1A) revealed that SeoC
from S. enterica subsp. arizonae and that from S. enterica subsp.
salamae share 83% sequence identity and 77%/78% identity, re-
FIG 1 Sequence alignment of EspJ homologues and protein translocation. (A) Sequence alignment of the EspJ homologues with consensus sequence. Residues
are colored red for high consensus, blue for low consensus, and black for neutral consensus. The conserved residues R79 andD187 crucial for EPEC EspJ activity
are highlighted with a black box. (B) Phylogenetic analysis of the EspJ homologues showing separation of EPEC, EHEC, and C. rodentium homologues from the
Salmonella homologues. A scale for point accepted mutations (PAM) is displayed. (C) S. enterica subsp. salamae SeoC is translocated via the SPI-1 (invA), but
not via the SPI-2 (ssaV) or LEE (escN), T3SS during S. enterica subsp. salamae infection of HeLa and J774.A1 cells. The T3SS effector SboI and FabI were used
as positive and negative controls, respectively. Results are averages from three experiments, each in quadruplicate wells. The error bars represent standard errors
of the means. Statistical analyses were performed with GraphPad Prism software using a one-way analysis of variance followed by Bonferroni posttest (*, P

0.01). Asterisks represent significance compared to uninfected cells; ns, not significant.
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spectively, to SboC from S. bongori. Between 56% and 58% se-
quence identity is shared between the Salmonella SeoC/SboC and
EspJ from EPEC, EPEC, and C. rodentium (see Table S6 in the
supplemental material). Sequence variation was concentrated at
the N-terminal 50 amino acids with only around 35% sequence
identity between the E. coli/C. rodentium and Salmonella homo-
logues (see Table S6). Typically, this region harbors a 20- to 30-
residue secretion signal, required for specific targeting to the cor-
rect secretion system. Phylogenetic analysis revealed that the
Salmonella and the E. coli/C. rodentium homologues fall on sepa-
rate branches in the tree (Fig. 1B). However, residues R79 and
D187, required for EPEC EspJ ART activity, are preserved in all
EspJ/SeoC homologues, suggesting a conserved catalytic function
(Fig. 1A, black box).
S. enterica subsp. salamae SeoC is translocated by the SPI-1
T3SS. In order to determine through which T3SS the S. enterica
subsp. salamae SeoC is translocated, translocation assays were
performed using wild-type (WT) S. enterica subsp. salamae and
FIG 2 Internalization of S. enterica subsp. salamae 3588/07 during infection of HeLa and J774.A1 cells. (A) WT and seoC S. enterica subsp. salamae strains do
not cause cell lysis compared to uninfected J774.A1 cells 30 or 60 min postinfection. Data represent the averages from three experiments, each in triplicate. UI,
uninfected; ns, not significant. (B) Gentamicin protection assay of HeLa cells infected withWT S. enterica subsp. salamae or seoC or invAmutant. There was
no significant difference between S. enterica subsp. salamaeWTandseoC strain invasiveness, while theinvA strainwas significantly less invasive than bothWT
and seoC strains. Results are the mean standard error of the mean from three or more independent experiments. Statistical analyses were performed with
GraphPad Prism software using a one-way analysis of variance followed by Bonferroni posttest (*, P
 0.01; ns, not significant). (C andD) J774.A1 (C) andHeLa
(D) cells were infectedwithWT S. enterica subsp. salamaeor theseoCorinvAmutant expressingGFP. External bacteriawere stainedwith anti-CSA-1 antibody
before cell permeabilization. All strains were internalized by J774.A1macrophages (C).WT andseoC strains invadedHeLa cells, while theinvA strain was not
invasive (D). Arrowheads indicate external bacteria. Bars, 10 m.
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LEE (escN), SPI-1 (invA), and SPI-2 (ssaV) T3SS nonfunc-
tional mutants expressing SeoC fused to the TEM-1 reporter. The
housekeeping/cytosolic protein FabI fused to TEM-1, used as a
negative control, was not translocated when expressed in WT S.
enterica subsp. salamae, while the S. bongori T3SS effector SboI,
which was used as a positive control, was translocated into both
HeLa cells and J774.A1 macrophages. SeoC-TEM was translo-
cated into both HeLa cells and J774.A1 macrophages following
infectionwithWT S. enterica subsp. salamae, and to a lesser extent
from the escN and ssaVmutants. In contrast, no translocation
was seen from the invA strain (Fig. 1C), suggesting that SeoC is
an SPI-1 effector.
S. enterica subsp. salamae invades phagocytic and epithelial
cells independently of SeoC. S. enterica subsp. salamae is mainly
isolated from extraintestinal infections (10). We therefore aimed
to investigate the invasion potential of S. enterica subsp. salamae
and any involvement of SeoC in this process, considering that EspJ
has an antiphagocytic activity, albeit of opsonized particles (16).
Salmonella expressing GFP (25) was used to infect HeLa cells and
J774.A1 macrophages. Lactate dehydrogenase (LDH) release, in-
dicative of cell lysis, measured 30 and 60 min after infection of
J774.A1 with WT and seoC S. enterica subsp. salamae, revealed
no significant increase over uninfected cells (Fig. 2A), suggesting
that these strains are not cytotoxic. Gentamicin protection inva-
sion assays showed that while S. enterica subsp. salamaeinvAwas
significantly less invasive into HeLa cells, no significant difference
was seen between the WT and S. enterica subsp. salamae seoC
strains (Fig. 2B). Extracellular bacterial staining, using the anti-
CSA-1 antibody prepermeabilization, confirmed that S. enterica
subsp. salamae and S. enterica subsp. salamaeseoC invaded both
phagocytic and epithelial cells (Fig. 2C and D). The SPI-1 T3SS-
deficient invA strain was still internalized by J774.A1 macro-
phages but unable to invade HeLa cells. Together, these data show
that, similarly to EspJ, SeoC does not play a role in inhibition of
cis-phagocytosis (uptake of nonopsonized bacteria).
SeoCADP-ribosylates Src E310.Wehave previously reported
that EPECEspJ inhibits Src byADP-ribosylation of E310within its
protein kinase domain (SH1) (17). In order to determine if SeoC
from S. enterica subsp. salamae and S. enterica subsp. arizonae,
SboC from S. bongori, and EspJ from EHEC and C. rodentium
share this activity, we performed an in vitro ADP-ribosylation
assay. Purified MBP-tagged effectors and GST-tagged Src-
SH1K295M/Y416F (Src-SH1KY; K295M, kinase dead; Y416F, auto-
phosphorylation mutant) were incubated with NAD-biotin and
then analyzed byWestern blotting. This revealed that SeoC, SboC,
and EspJ ADP-ribosylated GST-Src-SH1KY (Fig. 3, lower band,
streptavidin panel) and also had various levels of autoactivity (Fig.
3, upper band, streptavidin panel). No ADP-ribosylation was de-
tected using the negative control GST or when GST-Src was incu-
bated withMBP-EspJ-EPECR79A (ART catalytic mutant) or MBP.
Importantly, we detected no ADP-ribosylation of Src mutated at
residue E310 (Src-SH1KYE), suggesting that the target residue is
shared between SeoC, SboC, and EspJ.
Ectopic expression of SeoC inhibits FcRIIa-mediated
phagocytosis. Src kinase is involved in the regulation of many
cellular processes, including cell proliferation and differentiation,
cell motility, and phagocytosis (reviewed in reference 32). Src
phosphorylates the cytoplasmic immunotyrosine activation mo-
tifs (ITAMs) of FcRIIa, allowing the recruitment of Syk kinase
and initiating the signaling cascade for phagocytic actin remodel-
ing. To assess the inhibition of phagocytosis by the different SeoC/
SboC/EspJ homologues, we generated a Cos-7 cell line stably ex-
pressing FcRIIa. The cells were then transfected with the
different SeoC/SboC/EspJ homologues before being challenged
with IgG-opsonized beads. The internal/external localization of
cell-associated beads in transfected cells was observed by immu-
nofluorescence (Fig. 4A). Mock-transfected cells or cells trans-
fected with EPEC EspJR79A/D187A (ARTmutant) were used as neg-
ative controls. Immunofluorescence analysis showed that all the
SeoC/SboC/EspJ homologues reduced bead internalization from
60% in mock- and EspJR79A/D187A-transfected cells to below 10%
(Fig. 4B). Thus, the ADP-ribosylation of Src appears inhibitory,
and each effector is capable of inhibiting opsonophagocytosis, in-
dependently of other effector proteins.
FIG 3 Salmonella and E. coli EspJ homologues ADP-ribosylate Src E310 in vitro. MBP-tagged EspJ homologues bound to amylose resin were incubated with
Src-SH1KYE and 6-biotin-17-NAD
 (NAD-biotin) for 1 h and analyzed by Western blotting. ADP-ribosylated proteins were detected using a streptavidin-
horseradish peroxidase conjugate (top row), while the anti-GST antibody revealedGST-tagged Src-SH1KY/KYE (middle row) and the anti-MBP antibody revealed
MBP-tagged SeoC/SboC/EspJ (bottom row). The proteins detected by Western blotting are indicated with arrowheads on the right. All EspJ homologues were
able to ADP-ribosylate GST-Src-SH1KY but not GST-Src-SH1KYE. Numbers at left are molecular masses in kilodaltons.
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SeoC inhibits FcR-mediated phagocytosis during Salmo-
nella infection. To confirm the inhibitory activity of SeoC during
infection, J774.A1macrophages were infected withWT S. enterica
subsp. salamae, S. enterica subsp. salamae seoC, and S. enterica
subsp. salamaeseoC complemented with plasmids carrying seoC
or seoCR79A and then challenged with IgG-opsonized beads. Im-
munofluorescence revealed thatmacrophages infectedwithWT S.
enterica subsp. salamae displayed reduced phagocytosis of cell-
associated beads (
18%) compared to uninfected cells (57%) or
cells infected with S. enterica subsp. salamaeseoC (68%) (Fig. 5A
and B). S. enterica subsp. salamaeseoC complemented with seoC
restored inhibition of phagocytosis (26%), whereas the seoCR79A
strain had a level of phagocytosis similar to that of the seoC
mutant, confirming that ADP-ribosylation activity of SeoC is re-
quired for inhibition of phagocytosis.
DISCUSSION
In this study, genomic sequencing revealed the effector repertoire
of the SPI-1, SPI-2, and LEE T3SSs of S. enterica subsp. salamae
3588/07, a crucial determinant for bacterial infection strategies
and host specificities. For example, the absence of sseJ from Sal-
monella enterica serovar Typhi was linked to reduced cytotoxicity
in in vitro infection models (33). Similarly, a Salmonella enterica
serovar Typhimurium slrPmutant caused a colonization defect in
mice but had no effect in calves (34). Despite its importance in S.
Typhimurium, SlrP is not found in S. enterica subsp. salamae and
is observed only as a pseudogene inmany other Salmonella strains.
We observed six effector genes not previously seen in S. enterica
subsp. salamae. These were steA, steB, and steC, with unknown
function; sseK2, which is similar in sequence to the EPEC/EHEC
FIG 4 Ectopic expression of Salmonella EspJ homologues inhibits FcRIIa-mediated phagocytosis. Cos-7 cells stably expressing GFP-FcRIIa and transfected
with plasmids encodingMyc-tagged SeoC/SboC/EspJ homologues were challengedwith IgG-opsonized 3-mbeads. (A) Staining pre- and postpermeabilization
revealed external beads (red), total beads (blue), and SeoC/SboC/EspJ-transfected cells (green). Representative immunofluorescence images of pRK5-SeoC/
SboC/EspJ-transfected cells are shown. Arrowheads indicate the internalization of beads in SeoC/SboC/EspJ-transfected cells; dotted lines indicate the cell
outlines. Bars, 10 m. (B) Total/external cell-associated beads were counted for EspJ-transfected cells, revealing inhibition of bead phagocytosis by all SeoC/
SboC/EspJ homologues compared to mock-transfected (Mock) or EPEC EspJR79A/D187A (ARTmutant)-transfected cells. Results are the mean standard error
of the mean from three independent experiments. Statistical analyses were performed with GraphPad Prism software using a one-way analysis of variance
followed by Bonferroni posttest (*, P
 0.01; ns, not significant).
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anti-inflammatory effector NleB (35); the NF-B inhibitor with
E3 ligase activity sspH1 (36); and the guanine nucleotide exchange
factor (GEF) gene sopE. In S. Typhimurium, a sopE, sopE2, and
sopB triple mutant is noninvasive (37). Both sopE and sopE2 are
present in S. enterica subsp. salamae 3558/07, but sopB, which
contributes to invasion, fluid secretion, SCV development, and
intracellular survival (38, 39), and avrA, which also supports in-
tracellular survival (29), were absent. Desai et al. identified paral-
ogues of S. bongori effector SboH in S. enterica subsp. salamae
1582, SboK and SboL in S. enterica subsp. salamae 1583, and SboC
in both strains (12). S. enterica subsp. salamae 3588/07 possesses
SboK, which has no known function but is predicted to have a
domain organization similar to SlrP, and SboC, the predicted ho-
mologue of EPEC/EHEC EspJ. Strain 3588/07 was selected to rep-
resent the four of seven S. enterica subsp. salamae isolates origi-
nating from water bath areas. Differences in its effector repertoire
from those of other S. enterica subsp. salamae strains highlight that
the remaining six isolates are likely to possess unique subsets of
effectors, which could be revealed by further genome sequencing.
PCR screening showed that sboC/seoCwas present in S. bongori
(6 from 6), S. enterica subsp. salamae (4 from 7), and S. enterica
subsp. arizonae (8 from 9) isolates, but none of the S. enterica
subsp. diarizonae and S. enterica subsp. houtenae isolates tested. S.
bongori SboC is known to be translocated by the T3SS (14), and
this study shows that S. enterica subsp. salamae SeoC is mainly a
substrate of the SPI-1 T3SS. SeoC did, however, inhibit phagocy-
tosis during the infection of murine macrophages, as did the ec-
topic expression of all tested SeoC/SboC/EspJ homologues within
aGFP-FcRIIa-expressingCos-7 cell line. It is possible for effector
proteins to be substrates of more than one secretion system at
different stages of infection, as is the case for SlrP (40). For SeoC,
this could explain the reduction in translocation in LEE and SPI-2
T3SS mutant strains, which would be interesting to investigate
using secretion assays specific to each T3SS.
Salmonella and E. coli are members of the same Enterobacteri-
aceae family with common ancestry over 100 million years ago
(41). While pathogenic E. coli types such as EPEC and EHEC pos-
sess a LEE-encoded T3SS and have adapted an extracellular life-
style, the majority of Salmonella strains have SPI-1 and SPI-2
T3SSs for invasion and intracellular replication, respectively. The
SPI-1 T3SS was acquired prior to the divergence of S. bongori and
S. enterica, after which the SPI-2 T3SS was introduced, before
separation into further subspecies (42). Pathogenicity islands are
generally acquired by horizontal gene transfer but can also be
carried in integrative elements such as cryptic prophages (37).
Horizontal gene transfer has allowed the diversification and spe-
cialization of Salmonella infection strategies, and the distribution
of the SeoC/SboC/EspJ homologues in Salmonella and E. coli/C.
rodentium is a good example of this.
The presence of both SPI-1 and SPI-2 T3SSs in S. enterica
subsp. salamae and S. enterica subsp. arizonae suggests an intra-
cellular lifestyle, while the identification of a LEE-encodedT3SS in
S. enterica subsp. salamae could promote the opposite. It has been
reported that S. enterica subsp. arizonae and S. enterica subsp.
diarizonae are internalized poorly by J774.A1 macrophages (43).
Additionally, from a variety of Salmonella serovars isolated from
crocodiles, only subspecies enterica and not salamae or diarizonae
displayed invasive phenotypes in a mouse model system (44). In
fact, the presence of both SPI-1 and SPI-2 does not necessarily
confer invasiveness in vivo, as although the transfer of SPI-2 to S.
bongori increased intracellular persistence in cell culture, systemic
pathogenicity in a murine model was not possible (45). We
showed that S. enterica subsp. salamae can invade both J774.A1
andHeLa cells in a SeoC-independentmanner and lacks the actin-
rich pedestals characteristic of the LEE T3SS. This observation is
interesting considering the lack of sopB and avrA in S. enterica
subsp. salamae, which are key effectors for S. Typhimurium inva-
siveness and intracellular survival. For further characterization of
the salamae subspecies, it will be useful to investigate invasiveness
into other epithelial and macrophage cell lines. The SeoC-inde-
pendent invasiveness of S. enterica subsp. salamae shows that
SeoC, like EspJ, does not have a role in the inhibition of cis-phago-
cytosis.
Inhibition of phagocytosis by EPEC EspJ is mediated by ami-
FIG 5 SeoC inhibits FcRIIa-mediated phagocytosis during S. enterica subsp.
salamae infection of J774.A1 macrophages. J774.A1 macrophages were in-
fected with WT S. enterica subsp. salamae 3588/07 or seoC mutant with or
without complementation by pWSK29-SeoC/SeoCR79A (pseoC/pseoCR79A) be-
fore challenge with IgG-opsonized beads. (A) Representative immunofluores-
cence images are shown with external beads stained prepermeabilization
(green), total beads shown using differential interference contrast (DIC), and
bacteria stainedwith anti-CSA-1 (white).Macrophage outlines are shownwith
dotted lines. Arrowheads indicate the internalization of cell-associated beads
by infected macrophages. Bar, 10 m. (B) External and total cell-associated
beads were counted, revealing that infection with WT S. enterica subsp. sal-
amae 3588/07 reduced internalization from 57% of beads for uninfected cells
to 18.8%.Deletion of seoC removed the inhibition of phagocytosis, while com-
plementation with WT seoC but not seoCR79A (ART mutant) was able to re-
store the inhibition. Results are the mean standard error of the mean from
three independent experiments. Statistical analyses were performed with
GraphPad Prism software using a one-way analysis of variance followed by
Bonferroni posttest (*, P
 0.01).
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dation and ADP-ribosylation of the kinase domain of Src (17).
Many bacterial toxins possess ART activity, and several T3SS ef-
fector proteins with ART activity have been identified, including
Pseudomonas syringae HopF2, Pseudomonas aeruginosa ExoS and
ExoT, and Salmonella SpvB. HopF2 shares 20 to 25% sequence
identity with the SeoC/SboC/EspJ homologues and ADP-ribosy-
lates multiple mitogen-activated protein kinases (MAPKs) and
RIN4, inhibiting plant pathogen-associated molecular pattern
(PAMP)-triggered defenses (46, 47). The catalytic activity of SpvB
is essential for virulence of S. Typhimurium in mice (48), via the
modification of actin, a target for many ADP-R toxins, including
Clostridium botulinum C2, Clostridium perfringens iota toxin, and
the Clostridium difficile toxin (CDT) (49). Of the non-enterica
subspecies, spvB is present only in S. enterica subsp. arizonae,mak-
ing SeoC and SboC the first T3SS translocated ARTs identified in
S. enterica subsp. salamae and S. bongori. We showed that all the
EspJ homologues ADP-ribosylate E310 within the kinase domain
of Src, inhibiting Src-dependent phagocytosis signaling. ExoT also
inhibits phagocytosis and has many observed targets, including
Ras, ezrin/radixin/moesin (ERM) proteins, and Rab5 (50). As Src
E310 is highly conserved throughout the kinase superfamily, the
SeoC/SboC/EspJ homologues may, too, have additional targets,
the discovery of which is vital for uncovering the ultimate role of
these effectors. This could be pursued using proteomicmass spec-
trometry after Salmonella/E. coli infections to identify ADP-ribo-
sylated proteins or changes to the phosphoproteome indicating
the inactivation of target kinases.
The presence of SeoC/SboC/EspJ homologues in a subset of
bacteria with stark differences in their infection strategies displays
the importance of horizontal gene transfer for shaping the com-
plex T3SS effector repertoire of Enterobacteriaceae. It would be
interesting to study the consequences of expressing SeoC/SboC in
S. Typhimurium, which lacks this translocated enzyme, using the
mouse model of salmonellosis. In combination with powerful
mass spectrometry analysis, this will help uncover the ultimate
impact of these homologues on Salmonella infection strategies.
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